Related Experiment Videos
Cortisol in mood disorders.
1School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, UK. a.h.young@ncl.ac.uk
Stress (Amsterdam, Netherlands)
|July 16, 2005
Summary
Dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis is linked to mood disorders. Restoring glucocorticoid receptor (GR) function may improve depressive symptoms and cognitive deficits by lowering cortisol levels.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Molecular Biology
Background:
- Hypothalamic-pituitary-adrenal (HPA) axis dysfunction is a known feature of mood disorders.
- Hypercortisolaemia, often due to impaired glucocorticoid receptor (GR) negative feedback, may drive depressive symptoms and cognitive deficits.
Purpose of the Study:
- To investigate strategies for normalizing GR function to restore HPA axis integrity.
- To assess the therapeutic potential of up-regulating GRs for mood disorder symptoms.
Main Methods:
- Focus on preclinical and clinical studies.
- Investigating methods to lower circulating cortisol levels.
- Exploring the upregulation of GRs.
Main Results:
- Preliminary studies show encouraging results.
- Lowering cortisol levels by up-regulating GRs appears promising.
- Potential for improvements in depressive symptoms and cognitive functioning.
Conclusions:
- Targeting GR function represents a potential therapeutic avenue for mood disorders.
- Restoring HPA axis integrity through GR modulation may alleviate key symptoms.